passages.id: 1186
passages.type: sentence
passages.text: On two days , 60 COPD patients underwent dyspnea evaluation ( VAS score ) and pulmonary function testing at baseline and one hour after placebo or 300μg indacaterol administration .
entities.id: 1187
entities.type: intervention
entities.text: placebo
entities.id: 1188
entities.type: intervention
entities.text: indacaterol
entities.id: 1189
entities.type: outcome
entities.text: dyspnea evaluation ( VAS score )
entities.id: 1190
entities.type: outcome
entities.text: pulmonary function testing
entities.id: 1191
entities.type: participant
entities.text: 60 COPD patients